Search research articles
Contact Us
Filters
Showing results (341-350 of 688) with videos related to
Page
of 69
Sort By:
Circulation. Heart Failure
|
July 13, 2018
Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns
João Pedro Ferreira, Kevin Duarte, John J V McMurray, et al.
Heart (British Cardiac Society)
|
July 5, 2014
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
Dawn Lee, Koo Wilson, Ron Akehurst, et al.
European Journal of Heart Failure
|
September 16, 2025
An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction
Masatake Kobayashi, Kevin Duarte, João Pedro Ferreira, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 15, 2017
Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension
Csaba P Kovesdy, Lawrence J Appel, Morgan E Grams, et al.
Journal of the American Society of Hypertension : JASH
|
October 15, 2017
Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension
Csaba P Kovesdy, Lawrence J Appel, Morgan E Grams, et al.
JAMA Network Open
|
October 26, 2022
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis
Bertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 12, 2022
Prognostic relevance of magnesium alterations in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial
Pieter Martens, João Pedro Ferreira, John Vincent, et al.
European Heart Journal
|
February 5, 2008
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
Faiez Zannad, Wendy Gattis Stough, Bertram Pitt, et al.
ESC Heart Failure
|
January 26, 2018
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease
Bertram Pitt, David A Bushinsky, Dalane W Kitzman, et al.
The American Journal of Medicine
|
April 2, 2013
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension
Michael A Weber, George L Bakris, Allen Hester, et al.
Page
of 69
Search research articles
Search
Showing results (341-350 of 688) with videos related to
Sort By:
Page
of 69
Circulation. Heart Failure
|
July 13, 2018
Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns
João Pedro Ferreira, Kevin Duarte, John J V McMurray, et al.
Heart (British Cardiac Society)
|
July 5, 2014
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
Dawn Lee, Koo Wilson, Ron Akehurst, et al.
European Journal of Heart Failure
|
September 16, 2025
An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction
Masatake Kobayashi, Kevin Duarte, João Pedro Ferreira, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 15, 2017
Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension
Csaba P Kovesdy, Lawrence J Appel, Morgan E Grams, et al.
Journal of the American Society of Hypertension : JASH
|
October 15, 2017
Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension
Csaba P Kovesdy, Lawrence J Appel, Morgan E Grams, et al.
JAMA Network Open
|
October 26, 2022
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis
Bertram Pitt, Rajiv Agarwal, Stefan D Anker, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 12, 2022
Prognostic relevance of magnesium alterations in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial
Pieter Martens, João Pedro Ferreira, John Vincent, et al.
European Heart Journal
|
February 5, 2008
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
Faiez Zannad, Wendy Gattis Stough, Bertram Pitt, et al.
ESC Heart Failure
|
January 26, 2018
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease
Bertram Pitt, David A Bushinsky, Dalane W Kitzman, et al.
The American Journal of Medicine
|
April 2, 2013
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension
Michael A Weber, George L Bakris, Allen Hester, et al.
Page
of 69